Why Are Generic Drugs Being Held Up in Transit? Intellectual Property Rights, International Trade, and the Right to Health in Brazil and Beyond
Graduate studies at Western
Journal of Law, Medicine and Ethics 40 (2):197-205 (2012)
|Abstract||Access to medicines faces a new legal threat: “border enforcement” of drug patents. Using Brazil as an example, this article shows how the right to health depends on international trade. Border seizures of generic drugs present human rights and trade institutions with a unique challenge. Can public health advocates rise to meet it?|
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
|Through your library||Configure|
Similar books and articles
Rudolf V. van Puymbroeck (2010). Basic Survival Needs and Access to Medicines – Coming to Grips with TRIPS: Conversion + Calculation. Journal of Law, Medicine and Ethics 38 (3):520-549.
Joseph Millum (2008). Are Pharmaceutical Patents Protected by Human Rights? Journal of Medical Ethics 34 (11):e25-e25.
Thomas Alured Faunce, Global Intellectual Property Protection for Innovative Pharmaceuticals: Challenges for Bioethics and Health Law.
Michael Gorman (2005). Intellectual Property Rights, Moral Imagination, and Access to Life-Enhancing Drugs. Business Ethics Quarterly 15 (4):595-613.
Scott Wisor (2012). Property Rights and the Resource Curse: A Reply to Wenar. Journal of Philosophical Research 37:185-204.
Jonathan Liberman (2012). Combating Counterfeit Medicines and Illicit Trade in Tobacco Products: Minefields in Global Health Governance. Journal of Law, Medicine and Ethics 40 (2):326-347.
Meri Koivusalo (2010). Common Health Policy Interests and the Shaping of Global Pharmaceutical Policies. Ethics and International Affairs 24 (4):395-414.
Lisa Forman (2007). Trade Rules, Intellectual Property, and the Right to Health. Ethics and International Affairs 21 (3):337–357.
Patricia J. Arnold & Terrie C. Reeves (2006). International Trade and Health Policy: Implications of the GATS for US Healthcare Reform. [REVIEW] Journal of Business Ethics 63 (4):313 - 332.
Daniel Wei L. Wang & Octavio Luiz Motta Ferraz (2012). Pharmaceutical Companies Vs. The State: Who Is Responsible for Post-Trial Provision of Drugs in Brazil? Journal of Law, Medicine and Ethics 40 (2):188-196.
Michael A. Santoro, Human Rights and Human Needs: Diverse Moral Principles Justifying Third World Access to Affordable Hiv/Aids Drugs.
Simon Butt & Timothy Lindsey, Trips, Intellectual Property Law Reform in Indonesia: Why Injunctions Aren't Stopping Piracy.
Added to index2012-07-13
Total downloads4 ( #189,291 of 739,482 )
Recent downloads (6 months)1 ( #61,680 of 739,482 )
How can I increase my downloads?